According to the WHO, 30% of health expenditures are wasted on inefficient care and avoidable complications.
The Consortium VBHC is dedicated to the emergence of real-world data registries that measure the value of care according to standardised indicators that matter to patients.
One of the major weaknesses of health systems is that they measure treatment inputs rather than patient outcomes.
To address this, the Consortium VBHC accelerates the emergence of real-world data registries measuring patients’ health gains and Value-Based Health Care (VBHC).
The Consortium includes public and private institutions committed to:
- involving patients in health care evaluation (quality of life, functional recovery)
- allowing clinicians to compare themselves and improve their practices
- making health outcomes visible to all stakeholders
- helping patients navigate the health system and identify high-value care
The Value-Based Health Care (VBHC) approach measures patient outcomes relative to money spent.
Patient outcomes refer to a functional recovery and quality of life composite score.
- This score is measured through psychometric surveys scientifically validated.
- Patients' health gains, of clinical benefits, result from the score difference before, during and after treatment
- Scores are adjusted to patients' profiles, according to comorbidities and complications.
- This comparative analysis of real-world health gains identifies which care pathway generates the highest value for a specific patient profile and for the health system.
The Consortium VBHC was mandated by the European Union to publish a report in 2020 on the implementation of VBHC ecosystems.
Based on an analysis of 250 interviews of VBHC leaders across 22 EU countries, the handbook captures VBHC best practices. It offers a structured roadmap for implementation and presents case studies to help give rise to ecosystems based on high-value care.
interviews of VBHC leaders
EU countries analyzed
visits of pioneering sites
The Consortium is participating in the VBHC cataract experiment led by PromTime, funded by the French Ministry of Health and the National payer, the Assurance Maladie.
The experiment evaluates the appropriateness and transparency of cataract surgeries performed in the Nantes and Limoges regions.
This experiment introduces two pioneering innovations (Decree published in the Journal Officiel de la République Française on July 30, 2020):
- The open benchmark of average health gainsof participating clinicians
- An incentive payment for practitioners who share patients' health gains: The Financial Incentive for Advanced Transparency (FIAT)
Management team
Marie-Josée Augé-Caumon
Président of the VBHC Consortium
Jean-Pierre THIERRY
Vice-President and Secretary General of the VBHC Consortium
Scientific Advisory Board for the Cataract Registry
Pr. Béatrice Cochener
Ophtalmology Department, Brest University Hospital, President of the National Council of Ophthalmology Professionals
Dr. Vincent Dédes
Cabinet d'Ophtalmologie des Flandres, Syndicat National des Ophtalmologistes de France (National Union of Ophthalmologists of France)
Dr. François Lignereux
Sourdille-Atlantique Ophthalmological Institute, Delegate of the Scientific Council
Pr. Michel Weber
Ophthalmology department, Nantes University Hospital
